These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15546545)

  • 1. [Interferon and depression. Concerning a case].
    Lozano Arroyo I; Ruiz Carriedo E
    Aten Primaria; 2004 Nov; 34(8):442. PubMed ID: 15546545
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical benefits and cost-effectiveness of 17-year treatment with low-dose interferon-alpha 2b in a patient with chronic hepatitis C: a case report.
    Kawaguchi T; Sumie S; Itou M; Taniguchi E; Matoba T; Sata M
    Dig Dis Sci; 2009 Mar; 54(3):690-4. PubMed ID: 18661237
    [No Abstract]   [Full Text] [Related]  

  • 3. Adverse cutaneous reactions to interferon alfa-2b plus ribavirin therapy in patients with chronic hepatitis C virus.
    Manjón-Haces JA; Vázquez-López F; Gómez-Díez S; Hidalgo-García A; Pérez-Alvarez R; Soler-Sánchez T; Pérez-Oliva N
    Acta Derm Venereol; 2001; 81(3):223. PubMed ID: 11558891
    [No Abstract]   [Full Text] [Related]  

  • 4. Autoimmune thrombocytopenia induced by PEG-IFN-alpha2b plus ribavirin in hepatitis C.
    Sagir A; Wettstein M; Heintges T; Häussinger D
    Dig Dis Sci; 2002 Mar; 47(3):562-3. PubMed ID: 11911342
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cutaneous necrosis in patient with chronic hepatitis].
    García-Morán S; Sáez-Royuela F; Muñoz Fernández-Lomana C
    Rev Clin Esp; 2007 Feb; 207(2):95-6. PubMed ID: 17397573
    [No Abstract]   [Full Text] [Related]  

  • 6.  Pegylated interferon, but not conventional interferon therapy induced severe skin lesions.
    Li Z; Ji F; Zheng Y; An J; Peng Z
    Ann Hepatol; 2012; 11(4):570-1. PubMed ID: 22700642
    [No Abstract]   [Full Text] [Related]  

  • 7. [Necrotic lesion in a patient with hepatitis C virus liver disease under treatment with pegylated interferon].
    Rosel L; Blanco JR; Metota L; Oteo JA
    Enferm Infecc Microbiol Clin; 2004 Oct; 22(8):497-8. PubMed ID: 15482692
    [No Abstract]   [Full Text] [Related]  

  • 8. Severe streptococcal cellulitis after subcutaneous pegylated interferon alfa-2B in a diabetic patient.
    Lanternier F; Bon C; Memain N; Roulot D; Lortholary O
    Gastroenterol Clin Biol; 2004 Dec; 28(12):1294-5. PubMed ID: 15671943
    [No Abstract]   [Full Text] [Related]  

  • 9. Side effects of therapy for chronic hepatitis C.
    Russo MW; Fried MW
    Gastroenterology; 2003 May; 124(6):1711-9. PubMed ID: 12761728
    [No Abstract]   [Full Text] [Related]  

  • 10. Summaries for patients. Duration and dose of antiviral treatment for chronic hepatitis C.
    Ann Intern Med; 2004 Mar; 140(5):I67. PubMed ID: 14996694
    [No Abstract]   [Full Text] [Related]  

  • 11. [Chronic hepatitis C with early complication of Grave's disease during the treatment of pegylated interferon alpha-2a].
    Maede Y; Morishita K; Iwamura K; Takayama Y; Tsukada Y; Kishino M; Shimizu T; Matsushima S; Komatsu T; Kasagi Y
    Nihon Naika Gakkai Zasshi; 2005 Dec; 94(12):2600-2. PubMed ID: 16419601
    [No Abstract]   [Full Text] [Related]  

  • 12. Depression and hepatitis C.
    Sangwaiya A; Chan J; Ash S
    Br J Hosp Med (Lond); 2007 Dec; 68(12):682. PubMed ID: 18186414
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diabetes mellitus during interferon therapy].
    Tarabini-Castellani P; Apraiz L; Portu J; Agud JM
    Enferm Infecc Microbiol Clin; 2008 Feb; 26(2):120-1. PubMed ID: 18341927
    [No Abstract]   [Full Text] [Related]  

  • 14. [Peginterferon alfa-2b and ribavirin-induced pure red cell aplasia during treatment of chronic hepatitis C treated by cyclosporin A with good response].
    Kato M; Ryu T; Miura H; Yamada H; Saito T
    Nihon Naika Gakkai Zasshi; 2008 Jul; 97(7):1678-80. PubMed ID: 18681159
    [No Abstract]   [Full Text] [Related]  

  • 15. Emotional distress during interferon-alpha-2B and ribavirin treatment of chronic hepatitis C.
    Fontana RJ; Schwartz SM; Gebremariam A; Lok AS; Moyer CA
    Psychosomatics; 2002; 43(5):378-85. PubMed ID: 12297606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitiligo occurring at site of interferon-alpha 2b injection in a patient with chronic viral hepatitis C: a case report.
    Anbar TS; Abdel-Rahman AT; Ahmad HM
    Clin Exp Dermatol; 2008 Jul; 33(4):503. PubMed ID: 18498412
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pegylated interferon alfa-2a. Improved prognosis in hepatitis C].
    MMW Fortschr Med; 2002 Sep; 144(38):59. PubMed ID: 12395712
    [No Abstract]   [Full Text] [Related]  

  • 18. [Depressive symptoms during treatment with interferon alpha for HCV infection--preliminary report].
    Małyszczak K; Inglot M; Pawłowski T; Czarnecki M; Rymer W; Andrzej K
    Psychiatr Pol; 2006; 40(4):799-808. PubMed ID: 17068951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interferon-induced paranoid psychosis. Review of the literature and case report].
    Kornischka J; Burtscheidt W; Gaebel W
    Nervenarzt; 2002 May; 73(5):463-7. PubMed ID: 12078026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of the treatment of interferon-alpha-induced depression.
    Loftis JM; Hauser P
    Psychosomatics; 2003; 44(6):524-6. PubMed ID: 14597693
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.